Humana's pay-for-delay complaint against Bausch, Assertio partially dismissed by US judge
MLex Summary: Humana's antitrust complaint against Bausch, Assertio and Lupin, accusing the companies of deliberately delaying the market entry of generic versions of diabetes drug Glumetza, has been partially dismissed by...To view the full article, register now.
Already a subscriber? Click here to view full article